StageZero Life Sciences Ltd T.SZLS

ARISTOTLE and STAGEZERO

[Photoman77]

SZLS has a new focus and direction. I for one have not lost any money as I have purchased most fo my shares at these price levels.

Aristotle has launched and the company is currently putting deals in place regarding partnerships (yes, bashers will come in now with company made this promise before. Difference is, the product was not launched but now it is so deals are in the works and i am sure we will see new releases soon on this regarding insurance and physician agreements)

SZLS has a new COO (Cheif Operation Officer) and CFO (Cheif Financial Officer) with a big pharma background in Astra Zeneca. He will push the product and company to new highs.

SZLS has direction with how to sell Aristotle. Although sales figures will factor in Q4 2021 and beyond, share price reflects that but these prices wont last once company starts to release financials that include Aristotle sales and cross sales from Care Oncology treatment plan sales) 

Example: 50 Aristotle tests per day at $1500 USD equates to $2.2 million dollars ($2.8 million CAD) per month in revenue.100 test is $4.4 million per month and so on. The demand for this type of test will only grow.

Aristole test results that show any cancer will be followed up by Care Oncology (Health CLinic Comapany that SZLS bought this summer) that can provide treatment options for patients which become cross sales for revenue. Average cost to treat cancer in US is between $20,000 to $100,000 per patient.

Average of almost 2 million new cancer diagnosis per year in the US and that number will only continue to grow. 

SZLS is poised to see exponential growth in this sector.

References:

https://www.cancer.gov/about-cancer/understanding/statistics

https://www.cnbc.com/2020/10/22/how-much-breast-cancer-treatment-costs-even-with-health-insurance-.html

https://careoncology.com/

https://www.stagezerolifesciences.com/

I am not a paid pumer, I am not a company employee, I am an investor set to make a ton of money with this company with the return on my investment.

[4real4ever]

So much time wasted. Same CEO. Same product. Same director. Same bla,bla,bla In Stock Market "example", "maybe", "he can", "he say", "will", "should" doesn't work newbie. The reason for the $0,37 share price.   Only money, revenue, income and REAL deal with REAL companies works. **Take advices for your future**

[Proton3]

You are clearly new and inexperienced here and for sure was not around when they were trying to sell Colonsentry a very similar product and everyone was saying similar thing that you are now. Lets see, Photoman says 50 test per day, times 90 days in a quarter, equals 4500 test. Isn't their entire customer base only 10,000? That means at this rate they will have to test 50% for all their

[Proton3]

Nobody on the planet knows of this company. Just wait until they actually show decent Aristotle sales then you could jump in hard, its not like people are watching this. Much more safe. Holding into quartly performances which are always a total 100% guess has been extremly bloody over the years at almost every single one...

[Proton3]

Of coarse, knowbody will have a clue if they have even sold 5 tests until well into 2022.....wow.

[Liked2Think]

so you are going to get back into the "number of tests" game again? Where is the guy with the countless spreadsheet tables with the number of covid tests per day that they never even got to half of their so called "capacity" yet they talked about going to an even higher capactiy. Pumpers like to throw out numbers like they mean something. supposedly they are doing aristotle